Preference-based comparative effectiveness and cost–effectiveness: a review and relevance of value-based medicine for vitreoretinal interventions.

@article{Brown2012PreferencebasedCE,
  title={Preference-based comparative effectiveness and cost–effectiveness: a review and relevance of value-based medicine for vitreoretinal interventions.},
  author={Melissa M. Brown and Gary C Brown and Heidi B. Lieske and P Alexander Lieske},
  journal={Current opinion in ophthalmology},
  year={2012},
  volume={23 3},
  pages={163-74}
}
PURPOSE OF REVIEW This analysis discusses the comparative effectiveness and cost-effectiveness of vitreoretinal interventions, measured in quality-adjusted life years (QALYs) and percentage patient value (PPV gain, or improvement in quality of life and/or length of life). The material is relevant since the Patient Protection and Affordable Care Act enacted by Congress with the support of the President has emphasized the critical importance of patient-based preferences. RECENT FINDINGS The… CONTINUE READING

From This Paper

Topics from this paper.

Similar Papers

Loading similar papers…